Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier

被引:0
作者
Kong, Jing
Diao, Zhenyu
Deng, Xiaozhao
Zhong, Hui
Yao, Wenjuan
Hu, Xuefang
机构
[1] Huadong Res Inst Med & Biotech, Nanjing 210002, Peoples R China
[2] China Pharmaceut Univ, Coll Biol Sci & Technol, Nanjing 210009, Peoples R China
[3] Nanjing Normal Univ, Coll Life Sci, Nanjing 210097, Peoples R China
关键词
HBc particles; tumor associated antigen; epitope; growth factor receptor; ligand; cellular immunity; humoral immunity; hepatocellular carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. Tumor specific cellular and Immoral immunotherapy may be a viable approach for the treatment of HCC. This study investigated specific inhibitory and cytotoxic effects on hepatocellular carcinoma (HCC) induced by the peptide, designated HBc Delta-5L, using HBc carrier with multiple T cell and B cell sequence insertions. We developed the HBc Delta carrier containing insertions of multiple CTL and T helper (Th) epitopes, which were selected from HCC tumor associated antigens (TAAs) including a fetoprotein (AFP), melanoma antigen gene (MAGE) and telomerase reverse transcriptase (TERT) antigen, and ligands for EGFR and IGFR, designated HBc Delta-5L. LDH release assay and IFN-gamma ELISPOT assay were carried to determine whether HBc Delta-5L could induce specific cytotoxicity in peripheral blood mononuclear cells (PBMC) of HCC donors. The levels of antibodies and inhibitory effects of sera of immunized mice against HBc Delta-5L were also identified. LDH release assay revealed that PBMC from HCC donor group (n=8) stimulated with HBc Delta-5L could specifically kill target tumor cells and specific lysis was 62.7% (E:T=60: 1). ELISPOT assay showed a significant increase in secretion of IFN-gamma from PBMC of HCC donor group in response to HBc Delta-5L. Further, high specific antibody titers were elicited in immunized mice and revealed 42% inhibition of cell Growth. These results indicated that inhibitory and cytotoxic effects could be efficiently induced by HBc Delta-5L recombinant particles using HBc Delta as carrier and suggested that it could be important in design of immunotherapeutic approaches.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 38 条
  • [1] Intracellular signal transduction pathway proteins as targets for cancer therapy
    Adjei, AA
    Hidalgo, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) : 5386 - 5403
  • [2] Hepatocellular carcinoma
    Badvie, S
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2000, 76 (891) : 4 - +
  • [3] Bain I, 1997, SURGERY, V15, P169
  • [4] Cellular responses to interferon-gamma
    Boehm, U
    Klamp, T
    Groot, M
    Howard, JC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 749 - 795
  • [5] HYBRID HEPATITIS-B VIRUS NUCLEOCAPSID BEARING AN IMMUNODOMINANT REGION FROM HEPATITIS-B VIRUS SURFACE-ANTIGEN
    BORISOVA, G
    ARYA, B
    DISLERS, A
    BORSCHUKOVA, O
    TSIBINOGIN, V
    SKRASTINA, D
    ELDAROV, MA
    PUMPENS, P
    SKRYABIN, KG
    GRENS, E
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (06) : 3696 - 3701
  • [6] Determination of the fold of the core protein of hepatitis B virus ky electron cryomicroscopy
    Bottcher, B
    Wynne, SA
    Crowther, RA
    [J]. NATURE, 1997, 386 (6620) : 88 - 91
  • [7] T cell responses to HLA-A*0201-restricted peptides derived from human α fetoprotein
    Butterfield, LH
    Meng, WS
    Koh, A
    Vollmer, CM
    Ribas, A
    Dissette, VB
    Faull, K
    Glaspy, JA
    McBride, WH
    Economou, JS
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (08) : 5300 - 5308
  • [8] A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses
    Dakappagari, NK
    Pyles, J
    Parihar, R
    Carson, WE
    Young, DC
    Kaumaya, PTP
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (08) : 4242 - 4253
  • [9] A QUICK AND SIMPLE METHOD FOR THE QUANTITATION OF LACTATE-DEHYDROGENASE RELEASE IN MEASUREMENTS OF CELLULAR CYTO-TOXICITY AND TUMOR NECROSIS FACTOR (TNF) ACTIVITY
    DECKER, T
    LOHMANNMATTHES, ML
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 115 (01) : 61 - 69
  • [10] Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase
    Du, QY
    Wang, XB
    Chen, XJ
    Zheng, W
    Wang, SQ
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) : 2030 - 2035